AI Visibility Scorecard
hlrcc.org · Healthcare
Borderline visible. AI bots can crawl Hereditary Leiomyomatosis and Renal Cell Cancer, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 6 times
Meta AI · Claude · ShapBot
#46,659 of 924,420 in Healthcare for AI visibility
<1
4
AEO Visibility
iBorderline · 4.2/10
5
Muse Index Score
iAI agent readiness
Basic · 5/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
Hereditary Leiomyomatosis and Renal Cell Cancer is a business whose own site puts it this way: "Hereditary Leiomyomatosis and Renal Cell Cancer [email protected] +1 617-277-5667 ext." When AI engines look at it, they find little to work with. It scores 4.2 out of 10.
Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Good
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.2/10, Hereditary Leiomyomatosis and Renal Cell Cancer is crawlable but under-signaled - fixable, and the signals above are where to start.
How do I test for HLRCC?
HLRCC (Hereditary Leiomyomatosis and Renal Cell Cancer) genetic testing typically involves a blood or saliva sample, which is sent to a laboratory for analysis. Learn how to order an in home genetic test to see if you have HLRCC here.
How do I find a Clinical Care Center (CCC)?
To find a VHL and HLRCC dedicated Clinical Cancer Center (CCC) with a multidisciplinary team experienced in HLRCC, please click here. A list of CCCs are maintained by our partner, the VHL Alliance, and are dedicated to providing specialized care and support to individuals with HLRCC and other related conditions.
How do I enroll in the HLRCC Natural History Study or Seek Expert Guidance at the NIH?
To find out how to reach out to the NIH for expert opinion or to find an expert in HLRCC near you, please click here. The NIH offers a range of resources for individuals and healthcare providers managing HLRCC, including clinical trials and research initiatives aimed at improving outcomes for those affected by the condition.
How do I find a clinical trial?
Clinical trials are critical for advancing the treatment and management of HLRCC. By participating in clinical trials, individuals with HLRCC and variant histology renal cell cancer can potentially access new and innovative treatments.
I am a physician, where can I find more information?
For physicians and healthcare providers seeking more information about HLRCC, please click here. We provide a range of resources, including clinical guidelines, expert recommendations, and updates on ongoing research and clinical trials. We are dedicated to supporting healthcare providers in the diagnosis, management, and treatment of HLRCC.
Is this your brand?
The exact fixes for Hereditary Leiomyomatosis and Renal Cell Cancer
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Hereditary Leiomyomatosis and Renal Cell Cancer.
Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/hlrcc-org
Cite this score: Engagemii (2026). "AEO Score for Hereditary Leiomyomatosis and Renal Cell Cancer." Retrieved from https://engagemii.com/aeo/brands/hlrcc-org
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform